Jeindl, R. and Ettinger, S. (2023): Extracorporeal shock wave therapy for orthopaedic indications. Rapid Review Nr.: 002.

Ettinger, S. and Jeindl, R. (2023): Cipaglucosidase alfa (Pombiliti®) in combination with Miglustat for the treatment of adults with late-onset Pompe disease (acid α‑glucosidase [GAA] deficiency). Fact Sheet Nr. 124.

Jeindl, R. and Ettinger, S. (2023): iv Immunoglobulins (IgVena) in recurrent in vitro fertilisation implantation failure and/or recurrent pregnancy loss. Rapid Review Nr.: 001.

Jeindl, R. and Ettinger, S. (2023): Radiofrequency denervation for chronic lumbar or cervical spine pain. Rapid Review Nr.: 003.

Ettinger, S. and Jeindl, R. and Erdös, J. (2023): Biomarkers in Alzheimer's Disease. Rapid Review Nr.: 004.

Ettinger, S. and Wild, C. (2023): CORE-MD Roadmap for Education & Training: Perceived training needs of regulators, notified bodies and clinicians for successful implementation of the EU MDR. AIHTA Policy Brief 000.

Ettinger, S. and Mayer-Ferbas, J. and Jeindl, R. (2025): Serum eye drops for patients with severe ocular surface disease. Rapid Review Nr.: 017.

Ettinger, S. and Stanak, M. and Huić, M. and Hacek, R.T. and Ercevic, D. and Grenkovic, R. and Wild, C. (2016): Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk.. Decision Support Document 103.